Aug 2026· Nanoscale· Vol 18, pp. 19157 - 19164· 0 citations
Medicine
TL;DR
These findings establish strained-alkyne surface engineering as a powerful and modular strategy for imparting photodynamic functionality to carbon nanomaterials, advancing next-generation antimicrobial and antibiofilm technologies.
Abstract
Metal-free photoactive nanomaterials offer a promising strategy to address antimicrobial resistance, yet strategies enabling tuneable and efficient activity remain limited. Here, we introduce a materials-led approach to antibacterial photodynamic therapy by engineering carbon dots (CDs) with a strained dibenzocyclooctyne (DBCO) surface motif. Direct installation of the strained alkyne yields photoresponsive DBCO-CDs that exhibit potent, selective light-activated antibacterial activity. Under low-energy LED irradiation (395–405 nm), DBCO-CDs achieve >99.9% inactivation of Gram-positive bacteria, including Staphylococcus aureus, while remaining inactive in the dark and against Gram-negative bacteria. Mechanistic studies reveal that the intact strained alkyne is essential for activity, with non-strained-featuring analogues showing no efficacy. Reactive oxygen species (ROS)-trapping experiments implicate H2O2-mediated oxidative stress, while sub-cellular fluctuation imaging demonstrates rapid collapse of intracellular dynamics, consistent with metabolic failure. Notably, DBCO-CDs disrupt established biofilms, reducing biomass by 57% upon irradiation. Collectively, our findings establish strained-alkyne surface engineering as a powerful and modular strategy for imparting photodynamic functionality to carbon nanomaterials, advancing next-generation antimicrobial and antibiofilm technologies.
Antibiotic resistance continues to motivate non-antibiotic approaches for bacterial control. Antimicrobial photodynamic therapy (aPDT), which combines a photosensitizer, light, and oxygen to generate cytotoxic reactive oxygen species, offers a route to oxidative killing that is independent of conventional antibiotic...
Nahyun Kwon, Caitlyn Lee, Alicia Voge et al.· Journal of Porphyrins and Ph...· 0 citations
Photodynamic antimicrobial therapy (PDAT) offers a promising bactericidal strategy via light-triggered reactive oxygen species (ROS), yet conventional photosensitizers (PSs) typically lack sustained inhibitory activity. Herein, we attempt to redefine the functionality of PSs through a consensus-assisted design strategy...
Antimicrobial photodynamic therapy (aPDT) is an emerging approach to treat localised drug-resistant infections by generating reactive oxygen species with spatial and temporal control. Herein, we report the systematic assessment of six heteroleptic Cu(i) diimine-diphosphine photosensitisers of the type [Cu(N^N)(P^P)]+ a...
Alexander Dukalski, Çağrı Özsan, Florian Doettinger et al.· Dalton Transactions· 0 citations
This study designed two heavy-atom-free boron dipyrromethene (BODIPY) photosensitizers with aggregation-induced emission (AIE) to overcome the aggregation-caused quenching (ACQ) and alleviate heavy-atom toxicity, aiming to enhance the antimicrobial photodynamic therapy (aPDT) of conventional BODIPY. The resulting photo...
De-Chao Yang, Hang Zhu, Chang-Ying Wu et al.· Bioorganic chemistry (Print)· 0 citations
The overuse and misuse of antibiotics have accelerated the global antimicrobial resistance crisis, while the therapeutic efficacy of conventional antibiotics remains severely limited by dense biofilm barriers and the complex infectious microenvironment. To address these challenges, we developed an H2S-responsive nanodr...
Hongbo Juan, Xin Wang, Shan Sun et al.· Small· 0 citations
This work establishes a structure-guided design for carbon-based nanozymes and provides a safe, efficient platform for offering a non-antibiotic strategy to mitigate the risk of drug resistance.
Meng-Yao Yang, Jing-Tao Song, Xin Wang et al.· Journal of Colloid and Inter...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.